Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arkaitz Carracedo

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Science Signaling|March 10, 2011
Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectorsAtsuo T Sasaki, Arkaitz Carracedo, Jason W Locasale, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
SERS analysis of cancer cell-secreted purines reveals a unique paracrine crosstalk in MTAP-deficient tumorsPablo S Valera, Javier Plou, Isabel García, et al.
Nature|February 13, 2009
ETS rearrangements and prostate cancer initiationBrett S Carver, Jennifer Tran, Zhenbang Chen, et al.
Autophagy|August 5, 2009
TRB3 links ER stress to autophagy in cannabinoid anti-tumoral actionMaría Salazar, Arkaitz Carracedo, Iñigo J Salanueva, et al.
Nature Medicine|August 21, 2012
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenanceKeisuke Ito, Arkaitz Carracedo, Dror Weiss, et al.
Science Signaling|August 20, 2009
Differential p53-independent outcomes of p19(Arf) loss in oncogenesisZhenbang Chen, Arkaitz Carracedo, Hui-Kuan Lin, et al.
Pigment Cell & Melanoma Research|August 20, 2008
The antidepressant sertraline downregulates Akt and has activity against melanoma cellsKalpana K Reddy, Benjamin Lefkove, Lan Bo Chen, et al.
Journal of Personalized Medicine|December 9, 2020
Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate CancerClaudia Manini, Alba González, David Büchser, et al.
Nature Genetics|August 22, 2020
Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostateBrett S Carver, Jennifer Tran, Anuradha Gopalan, et al.
Molecular Oncology|October 21, 2025
Aggressive prostate cancer is associated with pericyte dysfunctionAnabel Martinez-Romero, Ane Martinez-Larrinaga, Joaquim Grego-Bessa, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Science Signaling|March 10, 2011
Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectorsAtsuo T Sasaki, Arkaitz Carracedo, Jason W Locasale, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
SERS analysis of cancer cell-secreted purines reveals a unique paracrine crosstalk in MTAP-deficient tumorsPablo S Valera, Javier Plou, Isabel García, et al.
Nature|February 13, 2009
ETS rearrangements and prostate cancer initiationBrett S Carver, Jennifer Tran, Zhenbang Chen, et al.
Autophagy|August 5, 2009
TRB3 links ER stress to autophagy in cannabinoid anti-tumoral actionMaría Salazar, Arkaitz Carracedo, Iñigo J Salanueva, et al.
Nature Medicine|August 21, 2012
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenanceKeisuke Ito, Arkaitz Carracedo, Dror Weiss, et al.
Science Signaling|August 20, 2009
Differential p53-independent outcomes of p19(Arf) loss in oncogenesisZhenbang Chen, Arkaitz Carracedo, Hui-Kuan Lin, et al.
Pigment Cell & Melanoma Research|August 20, 2008
The antidepressant sertraline downregulates Akt and has activity against melanoma cellsKalpana K Reddy, Benjamin Lefkove, Lan Bo Chen, et al.
Journal of Personalized Medicine|December 9, 2020
Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate CancerClaudia Manini, Alba González, David Büchser, et al.
Nature Genetics|August 22, 2020
Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostateBrett S Carver, Jennifer Tran, Anuradha Gopalan, et al.
Molecular Oncology|October 21, 2025
Aggressive prostate cancer is associated with pericyte dysfunctionAnabel Martinez-Romero, Ane Martinez-Larrinaga, Joaquim Grego-Bessa, et al.
Pageof 15